Skip navigation
PR Newswire

Liraglutide Beneficially Alters the Gut Microbiome in Type 2 Diabetes

WASHINGTON, Jan. 19, 2018 /PRNewswire/ -- An article published in Experimental Biology and Medicine (Volume 243, Issue 1, January, 2018) describes a new benefit for patients with type-2-diabetes (T2D) that take liraglutide. The study, led by Dr. Xinhua Xiao, from the Peking Union Medical...